Conclusions: SUV after CRT and SUV decrease (%) in FDG-PET of the primary tumor are useful tools to predict pathological response of neoadjuvant CRT for T4 esophageal SCC. PMID: 26902024 [PubMed - in process] (Source: Hepato-Gastroenterology)
MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.
from squamous cell carcinoma via ok on Inoreader http://ift.tt/1Q22F5W
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OvP3Mf
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου